Addex Therapeutics Ltd (ADXN) — Long-term Investment Intensity
Addex Therapeutics Ltd (ADXN) has a Long-term Investment Intensity of 60.2% as of September 2025. Long-term investments of CHF4.41 Million represent 60.2% of total assets of CHF7.33 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ADXN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Addex Therapeutics Ltd Long-term Investment Intensity (2024–2024)
This chart shows how Addex Therapeutics Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the intensity stands at 60.2%, reflecting long-term investments of CHF4.41 Million against total assets of CHF7.33 Million CHF. Explore Addex Therapeutics Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Addex Therapeutics Ltd (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Addex Therapeutics Ltd from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Addex Therapeutics Ltd worth.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 66.4% | CHF7.09 Million | CHF10.67 Million | — |